Articles with "mtor axis" as a keyword



Nicorandil mitigates amiodarone‐induced pulmonary toxicity and fibrosis in association with the inhibition of lung TGF‐β1/PI3K/Akt1‐p/mTOR axis in rats

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical and Experimental Pharmacology and Physiology"

DOI: 10.1111/1440-1681.13728

Abstract: The long‐term side effect of the antiarrhythmic drug, amiodarone (AMIO), such as lung toxicity, remains a critical clinical issue. The previous knowledge denotes diverse antioxidant, anti‐inflammatory, and antifibrotic properties of the anti‐anginal drug, nicorandil (NI).… read more here.

Keywords: pi3k akt1; mtor axis; amio; toxicity ... See more keywords

LncRNA-MALAT1 Regulates Cancer Glucose Metabolism in Prostate Cancer via MYBL2/mTOR Axis

Sign Up to like & get
recommendations!
Published in 2022 at "Oxidative Medicine and Cellular Longevity"

DOI: 10.1155/2022/8693259

Abstract: It is known that the long noncoding RNAs (lncRNA) MALAT1 is associated with tumorigenesis and progression in various cancers; however, its functions and mechanisms in prostate cancer (PCa) initiation and progression are still unknown. In… read more here.

Keywords: mtor axis; glucose metabolism; mybl2 mtor; malat1 ... See more keywords

Overexpression of the long non-coding RNA FOXD2-AS1 promotes cisplatin resistance in esophageal squamous cell carcinoma through the miR-195-Akt-mTOR axis.

Sign Up to like & get
recommendations!
Published in 2019 at "Oncology research"

DOI: 10.3727/096504019x15656904013079

Abstract: Emerging evidence has demonstrated that long-noncoding RNAs (lncRNAs) mediate the development of esophageal squamous cell carcinoma (ESCC) via various pathophysiological pathways. This study explored the impact of the lncRNA FOXD2-AS1 on cisplatin resistance in ESCC… read more here.

Keywords: cell; mtor axis; foxd2 as1; akt mtor ... See more keywords